Introduction The patient from the assigned case has a history of a heart attack at the age of 54. Therefore, they might belong to the elderly age group in addition to an already complicated cardiovascular health history. The patient is also diagnosed with harmful health conditions such as hypertension and hyperlipidemia. Lastly, they gained extra 10 pounds of weight during the COVID-19 outbreak, which could also have a negative effect on their heart and blood vessels. While heart attack, hypertension, hyperlipidemia, and weight gain are concerning conditions by themselves, the age factor and its possible influence on prescribed medications demand a special investigation. The impact of age on pharmacokinetics and pharmacodynamics might create the need to change the medication regimen. Age Influence on Pharmacokinetics and Pharmacodynamics The exact age of the patient from the assigned case is unknown. However, an already complicated health history allows to assume that the patient’s cardiovascular system is closer to older adults’ condition. As a result, the patient’s age might be affecting the current medication plan. Peeters et al. (2019) provided the following examples of age-related changes in drugs:   * Pharmacokinetics: distribution volume and half-lives. Older people usually have less muscle tissue, more fat tissue, and less body water percentage. As a result, the drugs accumulate in their bodies more easily, which can affect drug effectiveness and side effects;   * Pharmacodynamics: the patient from the assigned case has hypertension, which could result from age affecting their blood vessels. In addition, aging reduces cardiac contractility, which can lead to heart failure. In addition, Peeters et al. (2019) claimed that elderly patients often use several medications to treat chronic diseases, which leads to more drug-drug interactions and adverse effects. Therefore, it would be reasonable to lower the total number of medications so that an elderly patient could take only the drugs necessary for their condition. The dosage of certain medicines can be reduced as well in order to avoid unnecessary accumulation in the patient’s body and ease the drug’s excretion. Possible Impact on Drug Therapy The recommended drug therapy for the patient from the assigned case consists of the following medications:   * Atorvastatin: 80 mg daily;   * Lisinopril: 40 mg daily;   * Metoprolol succinate XL: 50 mg daily;   * Repatha: 140 mg/ml SC 2 weeks;   * Aspirin: 81 mg;   * Loratadine: 10 mg daily;   * Melatonin: 10 mg qhs;   * Omeprazole: prn The pharmacokinetics and pharmacodynamics specific to the elderly might cause polypharmacy and unnecessary accumulation of drugs. For example, an excessive accumulation of statins such as atorvastatin can cause dangerous conditions such as type 2 diabetes mellitus, hepatotoxicity, or renal toxicity (Ward et al., 2019). Moreover, negative drug-to-drug interactions can occur between the medications from the list — for instance, aspirin can potentially nullify the benefits of lisinopril (Drug Interactions between Aspir 81 and lisinopril, n.d.). Therefore, the existing therapy plan needs to be edited in order to lower the risks of